Skip directly to content

Advocating for TB Research Funding for BRICS and Beyond

Original air date - MAY 30, 2017

Inadequate funding for research has contributed to programs' inability to adequately address tuberculosis (TB), the leading infectious killer in the world. The first-ever Ministerial Conference on ending TB will be held in Moscow in November 2017, and will feature 8 thematic areas-- one of which is Scientific Research and Innovation. Webinar discussed necessary steps to make in advance of the Ministerial Conference to ensure strong, concrete commitments for TB research funding come out of it. The panelists discussed:
  • why TB research is essential and set targets for funding for it, 
  • walked through the example for garnering national commitment for investment in TB research from India, 
  • presented global leadership on TB research, 
  • proposed a concrete "ask" for TB research to come out of the Ministerial Conference. 
Panelists included: 
  • Mike Frick, Senior TB/HIV Project Officer, Treatment Action Group
  • Dr. Manjula Singh, Scientist 'E', Division of Epidemiology & Communicable Diseases, Coordinator India TB Research Consortium at the Indian Council of Medical Research. Speaking on behalf of Dr. Soumya Swaminathan, Director General, Indian Council of Medical Research
  • Dr. Mario Raviglione, Global Tuberculosis Programme Director, World Health Organization

Moderator: Marcus Low, Spotlight Editor and former Head of Policy at Treatment Action Campaign (TAC)

 

Presenter slides:
This is part 1 of a 2-part webinar series done in collaboration with ACTION in the lead-up to the first ever Ministerial meeting on TB being held in Moscow.